Pharmacogenomics and Immunosuppression in solid organ transplant patients

New Orleans, LA US
January 14, 2022

The purpose of this activity is to provide pharmacy technicians and pharmacists with the information and skills for the use of pharmacogenomics when initiating and managing immunosuppressive medications in solid organ transplant recipients. Variations in an individual’s genes can affect drug response, especially with the pharmacokinetics and pharmacodynamics of medications used in maintenance immunosuppression that have a narrow therapeutic index. Based on specific phenotypes, therapy plans for transplant immunosuppression can become more personalized to each patient. This will assist in avoiding harmful adverse effects and toxicities, as well as reaching therapeutic outcomes.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Discuss the use of personalized medicine and pharmacogenomics in different patient populations.
  2. Characterize pharmacogenomic factors that could alter pharmacokinetics and pharmacodynamics of immunosuppressive medications.
  3. Apply the principles of pharmacogenomics to evaluate the appropriate use of immunosuppressive medications.
  4. Evaluate the literature for outcomes of pharmacogenomic-tailored therapy in solid organ transplant recipients.

Pharmacy technician learning objectives

  1. Identify adverse effects of agents used in maintenance immunosuppression after solid organ transplant.

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
Course expires: 
Event starts: 
01/14/2022 - 1:00pm CST
Event ends: 
01/14/2022 - 2:00pm CST
Ochsner Medical Center
1514 Jefferson Hwy.
New Orleans, LA 70121
United States

Relevant financial relationships: Planning committee members and presenters have nothing to disclose.


Planning committee members
Stephanie Anders, PharmD
Solid Organ Transplant Clinical Pharmacist
Ochsner Medical Center


Samah Hammad, PharmD
PGY1 Oncology Pharmacy Resident
Ochsner Medical Center
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-22-039-L01-P
Universal Activity Number: JA0006103-9999-22-039-L01-T

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Please login or register to take this course.